H18.513
Endothelial corneal dystrophy, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Endothelial corneal dystrophy, bilateral (ICD-10 code H18.513), is a progressive eye condition affecting the inner layer of the cornea, known as the endothelium. The endothelium plays a crucial role in maintaining corneal transparency by regulating fluid levels within the cornea. When this layer develops dystrophic changes, it can lead to corneal swelling, cloudiness, and vision impairment. This condition typically impacts both eyes and may gradually worsen over time. Recognizing symptoms early and understanding the nature of this dystrophy can help patients seek appropriate eye care and management to preserve their vision.
Causes & Symptoms
Clinical Causes: Genetic mutations may cause abnormal development of the endothelial cells. Age-related degeneration of the corneal endothelium is common as part of the natural aging process. Certain syndromes or inherited eye disorders can predispose individuals to this dystrophy. Trauma or previous eye surgeries may contribute to the development of endothelial changes.
Key Symptoms: Gradual decline in vision, often described as blurry or hazy eyesight. Glistening or frosted appearance of the cornea upon examination. Sensitivity to bright lights or glare. Foreign body sensation or discomfort in the eye. In advanced stages, swelling of the cornea (corneal edema) leading to more significant vision problems.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination by an ophthalmologist, including slit-lamp microscopy to observe the corneal layers. Specular microscopy or pachymetry may be used to assess the endothelial cell count and corneal thickness. These assessments help confirm the presence and extent of endothelial dystrophy and distinguish it from other corneal conditions.
Treatment Protocols: Management of endothelial corneal dystrophy aims to alleviate symptoms and improve vision. Options include: - Regular monitoring to track disease progression. - Use of hypertonic saline eye drops or ointments to reduce corneal swelling. - Avoiding eye injury or irritation that could worsen the condition. - In advanced cases, corneal transplantation procedures such as endothelial keratoplasty (DSEK or DMEK) may be recommended to replace damaged endothelial cells. Early intervention often helps preserve vision and quality of life, making routine eye exams important for individuals at risk.
Clinical Advice & FAQs
Billing Guidance
Is H18.513 a billable ICD-10 code?
Yes, H18.513 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H18.513?
Clinical documentation must specify the nature of Endothelial corneal dystrophy, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference